The p101 subunit of PI3Kγ restores activation by Gβ mutants deficient in stimulating p110γ

Biochemical Journal

Volumn 441, Issue 3, 2012, Pages 851-858

  Shymanets, Aliaksei ^a,b   Ahmadian, Mohammad R ^b   Kössmeier, Katja T ^b   Wetzker, Reinhard ^c   Harteneck, Christian ^a   Nürnberg, Bernd ^a,b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

G ; G protein; p101; Phosphoinositide 3 kinase (PI3K ); Signal transduction

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PROTEIN G BETA; PROTEIN KINASE; PROTEIN P101; PROTEIN P110 GAMMA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; LIPID VESICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; CELLS, CULTURED; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; DRUG RESISTANCE; ENZYME ACTIVATION; GTP-BINDING PROTEIN BETA SUBUNITS; HUMANS; ISOENZYMES; LIPID METABOLISM; MODELS, MOLECULAR; MUTANT PROTEINS; PROTEOLYSIS; SPODOPTERA; TRANSFECTION; TRYPSIN;

EID: 84855978480     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20111664     Document Type: Article

References (53)

1. Kang, S., Denley, A., Vanhaesebroeck, B. and Vogt, P. K. (2006) Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 103, 1289-1294 (Pubitemid 43191158)
2. Fruman, D. A. and Bismuth, G. (2009) Fine tuning the immune response with PI3K. Immunol. Rev. 228, 253-272
3. Beer-Hammer, S., Zebedin, E., von Holleben, M., Alferink, J., Reis, B., Dresing, P., Degrandi, D., Scheu, S., Hirsch, E., Sexl, V. et al. (2010) The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation. J. Leukocyte Biol. 87, 1083-1095
4. Bunney, T. D. and Katan, M. (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat. Rev. Cancer 10, 342-352
5. Damilano, F., Perino, A. and Hirsch, E. (2010) PI3K kinase and scaffold functions in heart. Ann. N. Y. Acad. Sci. 1188, 39-45
6. Edling, C. E., Selvaggi, F., Buus, R., Maffucci, T., Di, S. P., Friess, H., Innocenti, P., Kocher, H. M. and Falasca, M. (2010) Key role of phosphoinositide 3-kinase class IB in pancreatic cancer. Clin. Cancer Res. 16, 4928-4937
7. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M. and Bilanges, B. (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell. Biol. 11, 329-341
8. Jamieson, S. M., Flanagan, J. U., Kolekar, S., Buchanan, C., Kendall, J. A., Lee, W. J., Rewcastle, G. W., Denny, W. A., Singh, R., Dickson, J. et al. (2011) A drug targeting only p110α can block PI 3-kinase signalling and tumour growth in certain cell types. Biochem. J. 438, 53-62
9. Brachmann, S. M., Yballe, C. M., Innocenti, M., Deane, J. A., Fruman, D. A., Thomas, S. M. and Cantley, L. C. (2005) Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Mol. Cell. Biol. 25, 2593-2606 (Pubitemid 40381624)
10. Shepherd, P. R. (2005) Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol. Scand. 183, 3-12
11. Geering, B., Cutillas, P. R., Nock, G., Gharbi, S. I. and Vanhaesebroeck, B. (2007) Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proc. Natl. Acad. Sci. U.S.A. 104, 7809-7814 (Pubitemid 47185833)
12. Ghigo, A., Damilano, F., Braccini, L. and Hirsch, E. (2010) PI3K inhibition in inflammation: toward tailored therapies for specific diseases. Bioessays 32, 185-196
13. Zhang, X., Vadas, O., Perisic, O., Anderson, K. E., Clark, J., Hawkins, P. T., Stephens, L. R. and Williams, R. L. (2011) Structure of lipid kinase p110β/p85β elucidates an unusual SH2-domain-mediated inhibitory mechanism. Mol. Cell 41, 567-578
14. Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P. and Hawkins, P. T. (1997) The Gβγsensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89, 105-114 (Pubitemid 27180590)
15. Leopoldt, D., Hanck, T., Exner, T., Maier, U., Wetzker, R. and Nürnberg, B. (1998) Gβγstimulates phosphoinositide 3-kinase-γ by direct interaction with two domains of the catalytic p110 subunit. J. Biol. Chem. 273, 7024-7029 (Pubitemid 28160369)
16. Maier, U., Babich, A. and Nürnberg, B. (1999) Roles of non-catalytic subunits in Gβγ -induced activation of class I phosphoinositide 3-kinase isoforms β and γ . J. Biol. Chem. 274, 29311-29317
17. Brock, C., Schaefer, M., Reusch, H. P., Czupalla, C., Michalke, M., Spicher, K., Schultz, G. and Nürnberg, B. (2003) Roles of Gβγ in membrane recruitment and activation of p110γ /p101 phosphoinositide 3-kinase γ . J. Cell Biol. 160, 89-99 (Pubitemid 36091719)
18. Voigt, P., Brock, C., Nürnberg, B. and Schaefer, M. (2005) Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase γ . J. Biol. Chem. 280, 5121-5127 (Pubitemid 40288688)
19. Hawkins, P. T., Anderson, K. E., Davidson, K. and Stephens, L. R. (2006) Signalling through class I PI3Ks in mammalian cells. Biochem. Soc. Trans. 34, 647-662 (Pubitemid 44796393)
20. Stoyanov, B., Volinia, S., Hanck, T., Rubio, I., Loubtchenkov, M., Malek, D., Stoyanova, S., Vanhaesebroeck, B., Dhand, R., Nürnberg, B. et al. (1995) Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269, 690-693
21. B phosphoinositide 3-kinase p110γ. Curr. Biol. 15, 566-570
22. PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase γ that is highly expressed in heart and interacts with PDE3B. J. Biol. Chem. 281, 9977-9986
23. 3 pools in mast cells. Sci. Signal. 2, ra27
24. B phosphoinositide 3-kinase p87/p110γ. Proc. Natl. Acad. Sci. U.S.A. 106, 20312-20317
25. Preuss, I., Kurig, B., Nürnberg, B., Orth, J. H. and Aktories, K. (2009) Pasteurella multocida toxin activates Gβγ dimers of heterotrimeric G proteins. Cell. Signal. 21, 551-558
26. Yu, J., Zhang, Y., McIlroy, J., Rordorf-Nikolic, T., Orr, G. A. and Backer, J. M. (1998) Regulation of the p85/p110 phosphatidylinositol 3-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit. Mol. Cell. Biol. 18, 1379-1387 (Pubitemid 28100902)
27. Yu, J., Wjasow, C. and Backer, J. M. (1998) Regulation of the p85/p110αphosphatidylinositol 3-kinase. Distinct roles for the N-terminal and C-terminal SH2 domains. J. Biol. Chem. 273, 30199-30203 (Pubitemid 28545483)
28. Shekar, S. C., Wu, H., Fu, Z., Yip, S. C., Nagajyothi, Cahill, S. M., Girvin, M. E. and Backer, J. M. (2005) Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit. J. Biol. Chem. 280, 27850-27855 (Pubitemid 41076901)
29. Wu, H., Yan, Y. and Backer, J. M. (2007) Regulation of class IA PI3Ks. Biochem. Soc. Trans. 35, 242-244 (Pubitemid 46596479)
30. Williams, R., Berndt, A., Miller, S., Hon, W. C. and Zhang, X. (2009) Form and flexibility in phosphoinositide 3-kinases. Biochem. Soc. Trans. 37, 615-626
31. Huang, C. H., Mandelker, D., Schmidt-Kittler, O., Samuels, Y., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., Gabelli, S. B. and Amzel, L. M. (2007) The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations. Science 318, 1744-1748 (Pubitemid 350274378)
32. Miled, N., Yan, Y., Hon, W. C., Perisic, O., Zvelebil, M., Inbar, Y., Schneidman-Duhovny, D., Wolfson, H. J., Backer, J. M. and Williams, R. L. (2007) Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317, 239-242 (Pubitemid 47076198)
33. Berndt, A., Miller, S., Williams, O., Le, D. D., Houseman, B. T., Pacold, J. I., Gorrec, F., Hon, W. C., Liu, Y., Rommel, C. et al. (2010) The p110δ structure: mechanisms for selectivity and potency of new PI3K inhibitors. Nat. Chem. Biol. 6, 117-124
34. Sun, M., Hillmann, P., Hofmann, B. T., Hart, J. R. and Vogt, P. K. (2010) Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α. Proc. Natl. Acad. Sci. U.S.A. 107, 15547-15552
35. Wu, H., Shekar, S. C., Flinn, R. J., El-Sibai, M., Jaiswal, B. S., Sen, K. I., Janakiraman, V., Seshagiri, S., Gerfen, G. J., Girvin, M. E. and Backer, J. M. (2009) Regulation of class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110α and are disrupted in oncogenic p85 mutants. Proc. Natl. Acad. Sci. U.S.A. 106, 20258-20263
36. Dbouk, H. A., Pang, H., Fiser, A. and Backer, J. M. (2010) A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 107, 19897-19902
37. Vogt, P. K. (2011) PI3K p110β: more tightly controlled or constitutively active? Mol. Cell 41, 499-501
38. 5γ2 is a highly selective activator of phospholipid-dependent enzymes. J. Biol. Chem. 275, 13746-13754
39. 3 formation monitored by a fluorescent Gβγ biosensor protein and repetitive two component total internal reflection/fluorescence redistribution after photobleaching analysis. Biochemistry 47, 11239-11250
40. 1γ2. Cell 83, 1047-1058
41. Lambright, D. G., Sondek, J., Bohm, A., Skiba, N. P., Hamm, H. E. and Sigler, P. B. (1996) The 2.0 Å crystal structure of a heterotrimeric G protein. Nature 379, 311-319
42. Ford, C. E., Skiba, N. P., Bae, H., Daaka, Y., Reuveny, E., Shekter, L. R., Rosal, R., Weng, G., Yang, C. S., Iyengar, R. et al. (1998) Molecular basis for interactions of G protein βγsubunits with effectors. Science 280, 1271-1274 (Pubitemid 28269623)
43. Smrcka, A. V., Lehmann, D. M. and Dessal, A L. (2008) G protein βγ subunits as targets for small molecule therapeutic development. Comb. Chem. High Throughput Screen. 11, 382-395 (Pubitemid 351830308)
44. Shymanets, A., Ahmadian, M. R. and Nürnberg, B. (2009) Gβγ-copurified lipid kinase impurity from Sf9 cells. Protein Pept. Lett. 16, 1053-1056
45. Czupalla, C., Culo, M., Müller, E. C., Brock, C., Reusch, H. P., Spicher, K., Krause, E. and Nürnberg, B. (2003) Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms β and γ. J. Biol. Chem. 278, 11536-11545 (Pubitemid 36792715)
46. Leopoldt, D., Harteneck, C. and Nürnberg, B. (1997) G proteins endogenously expressed in Sf9 cells: interactions with mammalian histamine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 356, 216-224 (Pubitemid 27341977)
47. Thomas, T. C., Sladek, T., Yi, F., Smith, T. and Neer, E. J. (1993) G protein βγ subunit: physical and chemical characterization. Biochemistry 32, 8628-8635 (Pubitemid 23270450)
48. Li, Y., Sternweis, P. M., Charnecki, S., Smith, T. F., Gilman, A. G., Neer, E. J. and Kozasa, T. (1998) Sites for Gα binding on the G protein β subunit overlap with sites for regulation of phospholipase Cβ and adenylyl cyclase. J. Biol. Chem. 273, 16265-16272 (Pubitemid 28311403)
49. 2 activation by the G protein βγ subunit map to the sides of the β propeller structure. J. Biol. Chem. 273, 28298-28304
50. Lodowski, D. T., Pitcher, J. A., Capel, W. D., Lefkowitz, R. J. and Tesmer, J. J. (2003) Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gβγ. Science 300, 1256-1262 (Pubitemid 36618232)
51. Czupalla, C., Nürnberg, B. and Krause, E. (2003) Analysis of class I phosphoinositide 3-kinase autophosphorylation sites by mass spectrometry. Rapid Commun. Mass Spectrom. 17, 690-696 (Pubitemid 36373169)
52. Sprang, S. R. (1997) G protein mechanisms: insights from structural analysis. Annu. Rev. Biochem. 66, 639-678
53. Davis, T. L., Bonacci, T. M., Sprang, S. R. and Smrcka, A. V. (2005) Structural and molecular characterization of a preferred protein interaction surface on G protein βγsubunits. Biochemistry 44, 10593-10604 (Pubitemid 41098236)